Related Experiment Video
Updated: Aug 9, 2026
09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
[Portal hypertension and angiogenesis]
Schweizerische Medizinische Wochenschrift
|March 17, 2000
Summary
Chronic portal hypertension involves vasodilation, with nitric oxide (NO) as a key mediator. New research shows NO drives increased blood vessel growth (angiogenesis) in portal hypertension, offering therapeutic targets.
Area of Science:
- Cardiovascular Physiology
- Gastroenterology
- Vascular Biology
Context:
- Chronic portal hypertension is characterized by complex hemodynamic alterations.
- The "forward theory" suggests vasodilation contributes significantly to these changes.
- Nitric oxide (NO) is recognized as a critical mediator of vasodilatory states.
Purpose:
- To investigate the role of angiogenesis and nitric oxide (NO) in the pathophysiology of chronic portal hypertension.
- To explore the mechanisms underlying systemic and splanchnic vasodilation in portal hypertension.
- To evaluate a novel in vivo angiogenesis assay for studying vascular alterations.
Summary:
- Rats with experimentally induced portal hypertension exhibited increased angiogenesis.
- Nitric oxide (NO) was identified as a mediator of this enhanced angiogenesis.
- Ongoing research focuses on the interactions between NO and other angiogenic molecules.
Impact:
- Improved understanding of the structural vascular changes in portal hypertension.
- Potential for developing novel therapeutic strategies targeting angiogenesis and NO pathways.
- Advancement in the study of vascular remodeling in liver disease.
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:17Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...